Hindustan Bio Sciences share price
You have to be logged in to add this to Watchlist.- ₹7.98(0.00%)May 13, 2025 15:15:00 PM IST
- NSE
- BSE
- Vol : 1.74K (NSE + BSE)Last 20 day avg : 3.51 K
Hindustan Bio Sciences is trading 0.00% upper at Rs 7.98 as compared to its last closing price. Hindustan Bio Sciences has been trading in the price range of 8.01 & 7.98. Hindustan Bio Sciences has given -21.84% in this year & -2.56% in the last 5 days. Hindustan Bio Sciences has TTM P/E ratio 40.64 as compared to the sector P/E of 42.23.The company posted a net profit of -0.04 Crores in its last quarter.Listed peers of Hindustan Bio Sciences include Ortin Global (4.57%), Shamrock Industrial (-%), Hindustan Bio Sciences (-%).The Mutual Fund holding in Hindustan Bio Sciences was at -% in . The MF holding has - from the last quarter. The FII holding in Hindustan Bio Sciences was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 13, 2025, 08:49 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/B10.17The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values31.76Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.24Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry3.18The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable- The company's revenue fell during December quarter by 100.00% from Rs 0.32 crore to Rs 0.00 crore, year-on-year
- Company has registered a loss of 0.04 cr vs a profit of 0.07 cr in the same quarter last year.
- The debt to equity of the company is higher than the industry median
- R1
- 8.45
- R2
- 8.72
- R3
- 9.19
- S1
- 7.71
- S2
- 7.24
- S3
- 6.97
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Ortin Global | Neutral | 10.99 | 4.57 | 8.94 | - | 2.94 | - | 63.82 |
| Shamrock Industrial | Bullish | 15.00 | - | 8.14 | - | 4.71 | - | - |
| Hindustan Bio Sciences | Moderately Bearish | 7.98 | - | 8.18 | 135.28 | 9.69 | - | 317.88 |
| Adline Chem Lab | Neutral | 13.59 | 1.95 | 7.95 | - | - | - | |
| Ganga Pharmaceuticals | Moderately Bearish | 13.51 | - | 6.53 | 191.60 | 0.93 | - | 5.60 |
- Promoter(s) does not have a high stake in the company
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-04-23 | Others |
| 2025-01-30 | Quarterly Results |
| 2024-10-30 | Quarterly Results |
| 2024-07-31 | Quarterly Results |
| 2024-05-25 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE597C01021
- BSE Code532041
- NSE Code
Hindustan Bio Sciences is trading at 7.98 as on Tue May 13 2025 09:45:00. This is 0.00% upper as compared to its previous closing price of 7.98.
The market capitalization of Hindustan Bio Sciences is 8.18 Cr as on Tue May 13 2025 09:45:00.
The 52 wk high for Hindustan Bio Sciences is 13.47 whereas the 52 wk low is 6.70
Hindustan Bio Sciences can be analyzed on the following key metrics -
- TTM P/E: 40.64
- Sector P/E: 42.23
- Dividend Yield: 0.00%
- D/E ratio: -
Hindustan Bio Sciences reported a net profit of 0.06 Cr in 2024.